Tocqueville Asset Management L.P. Purchases Shares of 59,318 Danaher Corporation $DHR

Tocqueville Asset Management L.P. bought a new position in Danaher Corporation (NYSE:DHR) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 59,318 shares of the conglomerate’s stock, valued at approximately $11,299,000.

A number of other institutional investors have also recently added to or reduced their stakes in DHR. BlackRock Inc. purchased a new position in shares of Danaher in the 2nd quarter worth about $10,492,520,000. Norges Bank acquired a new stake in Danaher during the 4th quarter worth approximately $2,177,106,000. Generation Investment Management LLP purchased a new position in Danaher in the second quarter valued at approximately $1,287,949,000. Flossbach Von Storch SE purchased a new stake in Danaher during the second quarter worth approximately $747,260,000. Finally, Bank of New York Mellon Corp acquired a new stake in shares of Danaher in the second quarter worth $712,875,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. HSBC decreased their price target on shares of Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research report on Wednesday, June 3rd. UBS Group decreased their target price on Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $240.00 target price on shares of Danaher in a research note on Wednesday, July 22nd. DZ Bank began coverage on Danaher in a report on Wednesday, June 3rd. They set a “buy” rating and a $210.00 target price on the stock. Finally, Wells Fargo & Company decreased their price target on Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a report on Wednesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $228.91.

Danaher Stock Up 6.2%

Shares of NYSE DHR opened at $211.92 on Thursday. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The firm has a market cap of $148.98 billion, a price-to-earnings ratio of 37.64, a PEG ratio of 2.49 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The stock’s 50-day simple moving average is $194.30 and its 200-day simple moving average is $192.44.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.Danaher’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.77 earnings per share. As a group, equities analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.